1. Aleksandrova N., Dubova E.A., Baev O.R. i dr. (2012). Markeri transmemranogo I enegeticheskogo obmena v kletkax terminalmix vorsin placenti pri spontannoy I inducirovannoy beremennosti. [Markers of transmembrane and energy metabolism in the cells of placental terminal villi in spontaneous and induced pregnancy. Cell technologies in biology and medicine]. Kletochnie texnologii v biologii i medicine (1), 19-23.

2. Bashmakova N.V., Kovalev V.V., Litvinova A.M. i dr. (2015). Vigivaemost I aktualnie perinatalnie texnologii pri vichajivanii novorojdennix s ekstremalno nizkoy massoy tela. [The survival rate of perinatal and current technology in the nursing of newborns with extremely low body weight]. Possiskyi vestnik akushera-ginekologa, (1), 4–7.

3. Bodneva D.N., Shmakov R.G., Shegolev A.I. (2013). Rol markerov invazii trofoblasta v razvitii preeklamsii i opucolevoy progressii. [The role of trophoblast invasion markers in the development of preeclampsia and tumor progression]. Akusherstvo i ginekologiya. (11), 9-12.

4. Jamaleeva P.S., Malceva L.I., Cherepanova N.A. i dr. (2016). Sostoyanie problem lecheniya i prognozirovaniya zaderjki razvitiya ploda. [The problem state of the treatment and prognosis of fetal growth retardation]. Prakticheskaya meditsina, 1 (93), 41–44

5. Milovanov A.P. (1999). Patologya sistemi mat-placenta-plod: posobye dlya vrachey. [Pathology of the mother-placenta-fetus system: A guide for doctors]. - M., 272.

6. Pavlov K.A., Dubova E.A., Shegolev A.I.(2013). Fetoplacentaniy angiogenez pri normalnoiy beremennosti: rol sosudistogo endotelialnogo faktora rosta. [Fetoplacental angiogenesis in normal pregnancy: the role of vascular endothelial growth factor. Obstetrics and gynecology]. Akusherstvo i ginekologiya ( 3), 11-6.

7. Rogova E.V., Barinov S.V., Dolgikh T.I. (2012). Znacheniye faktora rosta v geneze oslojneniy pri mnogoplodnoy beremennosti. [Significance of placental growth factor in the genesis of complications in multiple pregnancy]. Rossiyskiy vestnik akushera-ginekologa, 6, 7–9.

8. Senyavina N.V., Xustova S.А., Grebennik T.K., Pavlovich S.V. (2013) Analiz purinovix metabolitov v sivorotke materinsckoy krova dlya ocenki riska vozniknoveniya patologii beremennosti [Analysis of purine metabolites in maternal serum to assess the risk of pregnancy pathology]. Bulleten experimentalnoy biology i medicine. 155(5): 635-8.

9. Strizhakov A.N., Ignatko I.V., Timokhina E.V. et al. (2013). Sindrom zaderjki razvitiya ploda. Patogenes. Diagnostika. Lecheniye. Akusherskaya taktika: monographiya. [Fetal growth restriction syndrome. Pathogenesis. Diagnosis. Treatment. Obstetric management: monography], 120 р.

10. Suxix G.T., Vixlyaeva E.V., Vanko L.V. i dr. (2018). Endotelialnaya disfunkciya v geneze perinatalnoy patologii. [Endothelial dysfunction in the genesis of perinatal pathology]. Akusherstvo i ginekologiya; (5): 3–7.

11. Tezikov Yu.V., Lipatov I.S.(2012). Prognozirovaniye i diagnostika tyajelich form placentarnoy nedostatochnosti. [Prediction and diagnosis of severe placental insufficiency]. Akusherstvo i ginekologiya, (1): 35–42.

12. Shegolev A.I., Dubova E.A., Pavlov K.A. (2010)/ Morfologuya placenti. [The morphology of the placenta]. Moskva: 48s.

13. Abdulsid A., Hanretty K., Lyall F. (2013). Heat shock protein 70 expression is spatially distributed in human placenta and selectively upregulated during labor and preeclampsia. PLoS One. 8: е 54540.

14. Benirschke K., Burton G.J. Baergen R.N. (2012). Pathology of the human placenta. (6th ed.). New York: Springer; 939 р.

15. Burton G.J., Sebire N.J., Myatt L., Tannetta D., Wang Y.-L., Sadovsky Y. et al. (2014). Optimising sample collection for placental research. Placenta; 35: 9-22.

16. Chaiworapongsa T.I., Kusanovic J.P., Savasan Z.A. et al. (2010). Fetal death: a condition with a dissociation in the concentracions of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments. J. Matern. Fetal. Neonatal. Med.; 23 (9): 960–972.

17. Haavaldsen C., Samuelsen S.O., Eskild A. (2011). The association of maternal age with placental weight: a population-based study of 536,954 pregnancies. Br. J. Obstet. Gynaecol. ; 118(12): 1470-6.

18. Lascowska M., Lascowska K., Oleszczuk J. A. (2015). VEGF-A and its soluble receptor type-1 (sVEGFR-1, sFlt-1) concentracions in pregnancies with intrauterine growth restriction in the presence or absence of preeclampsia. Research J. Pharmaceu. Biol. Chemical.; 6 (2): 319–325.

19. Nomura Y., Lambertini L., Rialdi A., Lee M., Mystal E.Y., Grabie M. et al. (2014). Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity. Reprod. Sci.; 21(1): 131-7

20. Rodriguez-Prado Y.M., Kong X., Fant M.E. (2013). PLAC1 expression decreases in chorionic villi in response to labor. ISRN Obstet. Gynecol. 2013: 704252.